Trials / Completed
CompletedNCT00141505
PK Effects of Bifeprunox & Valproate in Bipolar I
Placebo-controlled Study on the Pharmacokinetics,Pharmacodynamics, Safety and Tolerability of Concurrent Valproate and Bifeprunox Administration in Subjects With Bipolar I Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is to evaluate the effect of bifeprunox on the pharmacokinetics of valproate in subjects with Bipolar I Disorder after multiple dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bifeprunox |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2005-09-01
- Last updated
- 2015-01-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00141505. Inclusion in this directory is not an endorsement.